We recorded migraine/headache characteristics every 10 min until 90 min after infusion start and collected blood to investigate mast cell degranulation and the inflammation markers tryptase and tumor necrosis factor-alpha (TNF-alpha) before and after infusion of PACAP38. Here, TNF is linked to migraine disorder.